Earnings Call Excerpt
PDL BioPharma Inc. (PDLI)
Q3 2008 Earnings Call
November 6, 2008 4:30 pm ET
Executives
Ami Knoefler - Head of Corporate and IR
Dr. Mark McCamish - Senior Vice President and Chief Medical Officer
Faheem Hasnain – President and CEO
Andrew Guggenhime - CFO
Mark McDade - CEO
Analysts
Joel Sendek - Lazard Capital Markets
Geoff Meacham - J.P. Morgan
Mark Monane - Needham & Company
Daniel Loeb - Third Point LLC
Tom McGahren - Merrill Lynch
Jennifer Chao - Deutsche Bank Securities
Bret Holey - CIBC World Markets
Phil Nadeau - Cowen and Company
Dave Hoffman
George Farmer - Wachovia Securities
Presentation
Operator
Good afternoon ladies and gentlemen, and welcome to the PDL BioPharma conference call. Today’s call is being recorded. For opening remarks and introductions I would now like to turn the call over to Miss Ami Knoefler, PDL’s head of Corporate and Investor Relations. Please go ahead.
Ami Knoefler
Good afternoon and thank you for joining us today Today’s call will begin with an introduction by Faheem Hasnain, our recently appointed President and CEO, followed by an update in our ongoing research and development activities by Dr. Mark McCamish, Senior Vice President and Chief Medical Officer, and the financial review of the quarter and an update on our spin-off process by Andrew Guggenhime, Senior Vice President and Chief Financial Officer.
After the conclusion of the prepared remarks we will open the call for questions. To ensure that everyone has an opportunity to address their questions we request a limit of one question and one follow up per person.
Before we begin, let me remind you that the information we will cover today contains forward looking statements regarding our financial performance, clinical milestones, and other matters, and our actual results may differ materially form those expressed or implied in the forward looking statements. Factors that may cause differences between current expectations and actual results are described in our filings with the Securities and Exchange Commission, copies of which may be obtained in the investors section of our website at pbl.com. the forward looking statements made in this presentation should be considered accurate only as of the date of this presentation, and although we may elect to update forward looking statements form time to time in the future, we specifically disclaim any duty or obligation to do so even as new information becomes available or other events occur in the future. It is now my pleasure to introduce Faheem Hasnain.
- To read the full transcript on Seeking Alpha, click here »
